In vitro studies have shown that overexpression of GATA1 in hematopoietic stem and progenitor cells (HSPCs) from DBA patients can rescue erythroid differentiation defects [1,31]. This evidence concerns the gene GATA1 and Diamond-Blackfan anemia.